Bile acid synthesis is believed to be regulated by bile salts returning to the liver via the portal vein and suppressing cholesterol 7a-hydroxylase, the rate-limiting enzyme in the bile acid biosynthesis pathway. In order to characterize the relative effectiveness of bile salts in regulating bile ac
Overexpression of cholesterol transporter StAR increases In Vivo rates of bile acid synthesis in the rat and mouse
β Scribed by Shunlin Ren; Phillip B. Hylemon; Dalila Marques; Emily Gurley; Patricia Bodhan; Elizabeth Hall; Kaye Redford; Gregorio Gil; William M. Pandak M.D.
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 886 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
Bile acid synthesis (BAS) occurs mainly via two pathways: the "neutral" pathway, which is initiated by highly regulated microsomal CYP7A1, and an "acidic" pathway, which is initiated by mitochondrial CYP27A1. Previously, we have shown that overexpression of the steroidogenic acute regulatory protein (StAR), a mitochondrial cholesterol transport protein, increases bile acid biosynthesis more than 5-fold via the acidic pathway in primary rat hepatocytes. This observation suggests that mitochondrial cholesterol transport is the ratelimiting step of BAS via this pathway. The objective of this study was to determine the effect of increased StAR on rates of BAS in viva Overexpression of StAR and CYP7A1 were mediated via infection with recombinant adenoviruses. BAS rates were determined in chronic biliary-diverted rats and mice, and in mice with an intact enterohepatic circulation.
The proteidmessenger RNA levels of StAR and CYP7A1 increased dramatically following overexpression. Overexpression of StAR or CYP7A1 led to a similar 2-fold (P < .01) increase in BAS over up-regulated (approximately 2-fold) 3-day chronic biliary-diverted control rats.
Additionally, overexpression of StAR led to more than 3and 6-fold increases over controls in the rates of BAS in biliary-diverted and intact mice, respectively (P < .01). In conclusion, in both rats and mice in vim, overexpression of StAR led to a marked increase in the rates of BAS initiated by delivery of cholesterol to mitochondria containing CYP27A1. (HEPATOLOGY 2004;40:910-917.) holesterol, a structural component of mammalian cell membranes, also serves as a precursor for C bile acids, steroid hormones, and vitamin D.' Under physiological conditions, cholesterol input into the body equals cholesterol output.1.2 In humans, hepatic
π SIMILAR VOLUMES
Acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitors are currently in clinical development as potential lipid-lowering and antiatherosclerotic agents. We investigated the effect of avasimibe (Cl-1011), a novel ACAT inhibitor, on bile acid synthesis and cholesterol 7β£hydroxylase in cultured
Oval cells are liver nonparenchymal epithelial cells most probably originating from the Hering canals or cells located near these canals in the periportal areas of the rat liver (1-3). They proliferate during hepatocarcinogenesis and chemically induced severe liver injury
The effect of bile duct ligation for 5 days on the hepatic transport of sulfated and nonsulfated bile acids was studied. Tracer doses of radioactive bile acids [3H]taurochenodeoxycholate-3-sulfate [3H]chenodeoxycholate-3-sulfate, [ 3 H ] t a ~r ~~h e n ~d e ~~y ~h o l i ~ acid and ['4C]taurocholic a
We examined the effects of feeding deoxycholic acid (1% and 0.4% of diet), alone and in combination with ursodeoxycholic acid, on serum and biliary bile acid concentrations, hepatic morphology, and the activities and steady-state messenger RNA (mRNA) levels of HMG-CoA reductase and cholesterol 7a-hy